Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer-Reference-Cited by-同舟云学术

Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer

Published:2017-10 Issue:5 Volume:15 Page:563-569.e3
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Muralidhar Vinayak,Mahal Brandon A.,Rose Brent S.,Chen Yu-Wei,Nezolosky Michelle D.,Efstathiou Jason A.,Beard Clair J.,Martin Neil E.,Orio Peter F.,Trinh Quoc-Dien,Choueiri Toni K.,Sweeney Christopher J.,Nguyen Paul L.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology, Prostate Cancer, 2016. Available at: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed: April 28, 2016.

3. Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis;Briganti;Eur Urol,2011

4. Radiation therapy for clinically node-positive prostate adenocarcinoma is correlated with improved overall and prostate cancer-specific survival;Tward;Pract Radiat Oncol,2013

5. The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study;Rusthoven;Int J Radiat Oncol Biol Phys,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in the Utilization of Radiation Therapy for Prostate Cancer in the United States: A Comprehensive Review;Advances in Radiation Oncology;2022-07

2. Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer;Frontiers in Oncology;2022-01-19

3. Disparities in Refusal of Locoregional Treatment for Prostate Adenocarcinoma;JCO Oncology Practice;2021-10

4. Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2021-04

5. Prostate cancer‐specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial priorities;The Prostate;2020-07-13